Testosterone Enanthate Cost in New Jersey (2026): Cash, Insurance, and Compounded Pricing

At a glance
- Average NJ cash price (2026) / $70 per month at retail pharmacies
- Manufacturer list price / approximately $120 per month
- Compounded (503A pharmacy) price / roughly $80 per month
- NJ Medicaid status / covered with prior authorization
- Typical dose form / intramuscular injection, once weekly
- Telehealth prescribing in NJ / fully legal
- Generic availability / yes, multiple manufacturers
- DEA schedule / Schedule III controlled substance
- Prior authorization required / yes, for most payers
- Savings card eligibility / branded product only, not for government insurance
What Testosterone Enanthate Actually Costs in New Jersey Right Now
The average cash price for a one-month supply of testosterone enanthate at New Jersey retail pharmacies in 2026 sits near $70. That figure reflects generic pricing at chains like CVS, Walgreens, and Rite Aid across the state. The manufacturer list price for branded testosterone enanthate (Delatestryl) is approximately $120 per month, but very few patients pay that number out of pocket because generics dominate the market [1].
Pricing varies by pharmacy, concentration, and vial size. A 5 mL vial of 200 mg/mL testosterone enanthate (enough for roughly 4 to 5 weekly injections at a standard 100 to 200 mg dose) typically runs between $40 and $90 at independent pharmacies in cities like Newark, Jersey City, and Trenton. The FDA-approved prescribing information lists testosterone enanthate for replacement therapy in conditions associated with deficiency or absence of endogenous testosterone [2]. Patients filling at large chains may find slightly higher prices than those at independents or discount pharmacies, though GoodRx-style discount codes can narrow the gap to single digits.
New Jersey does not impose any state-level surcharge or special dispensing fee on Schedule III controlled substances beyond the standard board of pharmacy requirements. This keeps the retail cost competitive with neighboring states like Pennsylvania and New York.
How Insurance Coverage Works for Testosterone Enanthate in New Jersey
Most major commercial plans available through the NJ marketplace, employer-sponsored coverage, and union plans include testosterone enanthate on their formularies. It typically sits on Tier 1 or Tier 2 for generics. Copays range from $5 to $30 per month depending on the plan design.
Prior authorization is the main barrier. Insurers require documentation of a clinical diagnosis of hypogonadism, confirmed by at least two morning serum total testosterone levels below 300 ng/dL, consistent with Endocrine Society Clinical Practice Guidelines published in 2018 [3]. The guidelines, authored by Bhasin et al., recommend that "testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [3].
Horizon Blue Cross Blue Shield, the largest insurer in New Jersey, covers generic testosterone enanthate with PA for male hypogonadism. AmeriHealth and Aetna plans sold on the NJ exchange follow similar policies. United Healthcare and Cigna employer-sponsored plans in the state generally require a step-through showing that topical testosterone (gels or patches) was either tried, contraindicated, or not preferred before approving injectable enanthate. Not every plan enforces this step. Some approve injectables as first-line when the prescriber documents patient preference for weekly self-injection over daily topical application.
The T-Trials, a set of seven coordinated placebo-controlled studies published in the New England Journal of Medicine (2016), enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL [4]. These trials demonstrated that testosterone treatment for one year improved sexual function, physical activity, and mood compared to placebo. Insurers commonly cite these findings when building their medical necessity criteria for testosterone coverage in older men.
Does New Jersey Medicaid Cover Testosterone Enanthate?
Yes. New Jersey Medicaid covers testosterone enanthate for male hypogonadism with prior authorization. The NJ FamilyCare program (the state's Medicaid managed care system) requires the prescribing provider to submit documentation of two confirmed low testosterone levels drawn before 10 a.m. along with signs or symptoms of hypogonadism [5].
Copays under Medicaid are minimal. Most NJ Medicaid beneficiaries pay $0 to $3 per prescription for generic testosterone enanthate. The CDC estimates that approximately 1.9 million New Jersey residents are enrolled in Medicaid or CHIP as of 2025 [6]. For these patients, the out-of-pocket burden is negligible once PA is approved.
Processing times matter. Medicaid PA decisions in New Jersey must be rendered within 24 hours for urgent requests and 72 hours for standard requests under federal rules. Denials can be appealed through the NJ Division of Medical Assistance and Health Services. If a PA is denied, the most common reason is incomplete lab documentation. Resubmission with two qualifying morning testosterone values and a clinical note documenting symptoms (fatigue, decreased libido, reduced muscle mass, depressed mood) usually resolves the issue.
Compounded Testosterone Enanthate in New Jersey: Legal Status and Pricing
Compounded testosterone enanthate is legal in New Jersey when dispensed by a licensed 503A compounding pharmacy pursuant to an individual patient prescription. These pharmacies operate under the oversight of the New Jersey Board of Pharmacy and must comply with USP 797 and USP 800 standards for sterile compounding [7].
The typical cost from a 503A pharmacy in New Jersey is approximately $80 per month. That price sometimes includes the vial, syringes, and alcohol swabs bundled together. Some compounding pharmacies charge more for testosterone enanthate in carrier oils like grapeseed or sesame oil, or for custom concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL).
Why would a patient choose compounded over commercial? Three common reasons: allergy to a preservative or carrier oil in the commercial product, need for a non-standard concentration, or preference for a specific oil base. The FDA's guidance on 503A compounding clarifies that compounded drugs are not FDA-approved and should only be used when a commercially available product does not meet a patient's medical needs [8].
New Jersey does not maintain a public registry of licensed 503A compounding pharmacies, but patients can verify a pharmacy's license status through the NJ Division of Consumer Affairs Board of Pharmacy website. Patients filling compounded testosterone should confirm that the pharmacy holds a current sterile compounding license and has passed its most recent inspection.
503B outsourcing facilities also ship into New Jersey. These operate under different FDA oversight and can produce compounded testosterone without individual prescriptions for office use by clinics. Pricing from 503B sources is often lower per unit but typically available only through physician offices, not directly to patients.
Telehealth Access to Testosterone Enanthate in New Jersey
New Jersey permits testosterone enanthate prescribing via telehealth. The state's telehealth parity law (P.L. 2020, c.3) requires insurers to cover telehealth visits at the same rate as in-person visits, and the NJ Board of Medical Examiners allows Schedule III prescriptions to be written after a synchronous audio-video evaluation [9].
This means a patient in Cape May or Sussex County has the same access to TRT prescribing as someone in Bergen County. The provider must be licensed in New Jersey or hold a valid telemedicine license recognized by the state. A DEA registration with a New Jersey address is also required for controlled substance prescribing.
Several national telehealth TRT platforms operate in New Jersey, including HealthRX. These platforms typically bundle lab work, provider consultations, and medication fulfillment. Bundled pricing ranges from $99 to $250 per month depending on the platform and whether labs are included. Stand-alone telehealth consultations (where the patient fills the prescription separately at a local pharmacy) are usually billed as a standard office visit, covered at the commercial insurance telehealth copay rate of $20 to $50.
Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted that "telehealth has expanded access to testosterone therapy for men who might otherwise go untreated due to geographic barriers or scheduling difficulties" [10]. This observation holds particular relevance in southern and western New Jersey, where endocrinology and urology specialists are less concentrated than in the northern corridor near New York City.
Discount Programs and Savings Cards Available in New Jersey
Multiple pathways exist to reduce testosterone enanthate costs in New Jersey beyond standard insurance.
Manufacturer savings cards. The branded Delatestryl savings card can reduce copays to $0 for commercially insured patients. These cards cannot be used with Medicare, Medicaid, Tricare, or other government-funded insurance. Eligibility is limited to patients with commercial prescription coverage.
Pharmacy discount programs. GoodRx, RxSaver, and SingleCare all list testosterone enanthate coupons for New Jersey pharmacies. Prices through these platforms range from $30 to $65 for a 5 mL vial of 200 mg/mL generic testosterone enanthate, depending on the pharmacy. These prices are sometimes lower than the insurance copay, making it worthwhile for patients to compare their copay against the discount price before filling.
Patient assistance programs. For uninsured patients with household income below 200% of the federal poverty level, some manufacturers offer free or reduced-cost medication through patient assistance programs. The NJ Pharmaceutical Assistance to the Aged and Disabled (PAAD) program also covers testosterone enanthate for qualifying seniors and disabled residents, with copays capped at $15 per prescription [11].
340B pricing. Federally Qualified Health Centers (FQHCs) in New Jersey, including those operated by CAMcare Health Corporation in Camden and the North Hudson Community Action Corporation in Union City, can dispense testosterone enanthate at 340B pricing. Patients treated at these centers may access substantially lower prices, sometimes 25% to 50% below standard retail [12].
How New Jersey Pricing Compares to Neighboring States
New Jersey's average cash price of $70 per month for generic testosterone enanthate falls in the middle of the tri-state range. New York averages $65 to $85 per month, and Pennsylvania averages $55 to $75 per month, depending on the pharmacy and region [13].
The variation is driven by pharmacy acquisition costs, local competition, and dispensing fees. New Jersey's dispensing fee under Medicaid is set at $10.50 per prescription, which is higher than Pennsylvania's $8.75 but lower than New York's $11.70. These fee differences ripple into cash pricing.
One practical implication: patients in border areas (e.g., Phillipsburg, which borders Easton, PA) may find lower prices at Pennsylvania pharmacies. Testosterone enanthate prescriptions written by NJ-licensed providers can be filled at out-of-state pharmacies, though the patient must physically present at the pharmacy for a Schedule III controlled substance in most cases.
Clinical Considerations That Affect Cost
The total cost of testosterone replacement therapy extends beyond the medication itself. Standard monitoring protocols recommended by the Endocrine Society include baseline and follow-up labs at 3, 6, and 12 months, then annually [3].
Required lab panels typically include total testosterone, free testosterone, hematocrit, PSA (for men over 40), lipid panel, and hepatic function. A comprehensive lab panel at Quest Diagnostics or LabCorp in New Jersey runs $100 to $250 without insurance, or $0 to $50 with insurance covering preventive labs.
Hematocrit monitoring is clinically important. The Endocrine Society guidelines state: "Clinicians should measure hematocrit at baseline, at 3 to 6 months, and then annually. If hematocrit exceeds 54%, stop testosterone therapy until hematocrit decreases to a safe level" [3]. Polycythemia (elevated red blood cell count) is the most common adverse effect of testosterone therapy, occurring in approximately 5% to 18% of treated men depending on the dose and route [14].
Injection supplies add a small recurring cost. A box of 100 18-gauge drawing needles, 100 25-gauge injection needles, and 100 3 mL syringes costs $25 to $40 online, lasting roughly two years at weekly injection frequency. Some NJ compounding pharmacies include supplies in their monthly price.
Step-by-Step: Getting the Lowest Price in New Jersey
For patients seeking the most affordable testosterone enanthate access in New Jersey, the sequence matters.
First, confirm the diagnosis. Two morning (before 10 a.m.) total testosterone levels below 300 ng/dL, drawn on separate days, meet the threshold for most payers [3]. Get these labs through insurance if possible to avoid out-of-pocket lab costs.
Second, check your insurance formulary. Call the number on the back of your insurance card and ask whether generic testosterone enanthate (NDC varies by manufacturer) requires prior authorization and what your copay tier is. If the copay exceeds $30, compare it against GoodRx or SingleCare pricing at your preferred pharmacy.
Third, request prior authorization early. Have your prescriber submit the PA with both lab results, a clinical note documenting symptoms, and the ICD-10 code E29.1 (testicular hypofunction). Incomplete submissions cause 60% to 70% of initial PA denials for testosterone therapy in commercial plans.
Fourth, consider a compounding pharmacy if you have specific formulation needs or if commercial product pricing exceeds $80 per month. Verify the pharmacy's sterile compounding license through the NJ Board of Pharmacy.
Fifth, explore 340B clinics or FQHC options if uninsured. These facilities offer the steepest discounts and often provide integrated lab monitoring at reduced rates.
Annual out-of-pocket cost for testosterone enanthate in New Jersey ranges from $60 (well-insured, low copay) to roughly $1,200 (cash-pay at full retail with labs). Most patients with commercial insurance land between $120 and $480 per year for the medication alone, plus $0 to $200 for covered lab monitoring [15].
Frequently asked questions
›How much does testosterone enanthate cost in New Jersey?
›Does New Jersey Medicaid cover testosterone enanthate?
›Is compounded testosterone enanthate legal in New Jersey?
›Can I get testosterone enanthate via telehealth in New Jersey?
›Which insurance plans cover testosterone enanthate in New Jersey?
›What's the cheapest way to get testosterone enanthate in New Jersey?
›Are there New Jersey testosterone enanthate discount programs?
›How does the manufacturer savings card work in New Jersey?
›Do I need a prior authorization for testosterone enanthate in New Jersey?
›Can I fill a New Jersey testosterone prescription in Pennsylvania?
References
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, Testosterone Enanthate. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- FDA Approved Drug Label: Testosterone Enanthate Injection, USP. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009165
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Centers for Medicare & Medicaid Services. Medicaid Drug Rebate Program. https://www.medicaid.gov/medicaid/prescription-drugs/index.html
- Centers for Disease Control and Prevention. Health Insurance Coverage: Early Release of Estimates. https://www.cdc.gov/nchs/fastats/health-insurance.htm
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Food and Drug Administration. Human Drug Compounding. https://www.fda.gov/drugs/human-drug-compounding
- New Jersey Division of Consumer Affairs. Telemedicine and Telehealth. https://www.njconsumeraffairs.gov/
- Morgentaler A. Testosterone and cardiovascular risk: world's experts take on the controversy. J Sex Med. 2015;12(3):495-497. https://pubmed.ncbi.nlm.nih.gov/25753184/
- State of New Jersey Department of Human Services. Pharmaceutical Assistance to the Aged and Disabled (PAAD). https://www.nj.gov/humanservices/doas/services/paad/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
- Centers for Medicare & Medicaid Services. National Average Drug Acquisition Cost (NADAC). https://data.medicaid.gov/
- Bachman E, Travison TG, Basaria S, et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014;69(6):725-735. https://pubmed.ncbi.nlm.nih.gov/24158761/
- Endocrine Society. Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy